This page is no longer updated.
It was archived on 8 July 2008 and is kept for historical purposes only. The latest content is available at http://www.who.int/selection_medicines/en/
![]() |
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies |
|
||
|
Venue: WHO Headquarters, |
||||
|
Key readings |
Programme |
PPT Presentations |
|
|
|
Monday 8
October 2007 Facilitation: Dr Richard Laing, PSM/PAR |
||||
| Registration |
08.30-09.00 |
M-505, M-Building, WHO/Headquarters | ||
| Introduction | ||||
| 09.00-09.30 | Welcome -
Objectives of the Seminar
Dr Hans Hogerzeil, Director PSM |
|||
| 09.30-10.15 | Introduction of
participants: Gallery of experts Dr Richard Laing, PSM/PAR and Dr Shanthi Pal, QSM |
|||
| 10.15-10.45 | Coffee | |||
| 10.45-11.00 | Seminar
overview and administration Mrs Helen Tata Mrs Ann Wilberforce |
|||
| 11.00-12.00 | PSM and TCM roles and responsibilities in implementing the WHO Medicines Strategy | |||
| Dr Hans Hogerzeil, Director PSM | ||||
Background documentation:
WHO Medicines Strategy: 2004-2007 |
||||
| 12.00-12.30 |
Information resources Mr Claude
Da Re, Mrs Kath Hurst, Mrs Christine Encrenaz and Mrs Daniela Bagozzi, Mr
Jörg Hetzke, Mr Thiago Miranda |
|||
| 12.30-14.00 | Lunch | |||
| National Drug Policies | ||||
|
14.00-14.30 |
National Medicines Policies Background documentation:
How to develop
and implement a national drug policy |
|||
|
14.30-15.30 |
Indicators on pharmaceutical situations Background documentation:
Fact book on WHO Level I & II Monitoring Indicators -- Households Survey
document |
|||
|
15.30-15.45 |
Tea | |||
| Selection of Essential Medicines | ||||
| 15.45-17.15 |
Update 2006 WHO Model List of Essential Medicines Selection, and Paediatric
Medicines Dr Suzanne Hill, PSM/PAR
Background documentation:
The Selection and Use of Essential Medicines |
|||
| 17.30-19.00 |
Reception (Classic Cocktail) with PSM & TCM staff members (WHO Restaurant, Main Building) |
|||
|
Tuesday 9
October 2007 Facilitation: Dr Sabine Kopp, PSM/QSM |
||||
| What is quality? | ||||
| 09.00-10.45 |
Medicines - Quality Control and Assurance WHO normative functions in the field of pharmaceuticals |
|||
| Dr Lembit Rago | ||||
| Dr Sabine Kopp, PSM/QSM | ||||
|
Background documentation:
Effective medicines regulations |
||||
| 10.45-11-00 | Coffee | |||
| 11-00-12.30 | Medicines - Quality Control and Assurance (continued) | |||
| 12.30-14.00 | Lunch | |||
| Prequalification | ||||
| 14.00-15.45 |
Prequalification of essential medicines Dr Lembit Rago, Dr Raul Kiivet and Dr Andre Van Zyl, PSM/QSM
Prequalifying Priority Medicines |
|||
| 15.45-16.00 | Tea | |||
| 16.00-17.00 |
Quality Control Assurance for Blood Products and Related Biologicals Dr Ana Padilla, PSM/QSD |
WHO Norms and Standards: Blood Products & related Biologicals |
||
| Evening | Dinner, Geneva (Optional: all have to pay for themselves: sorry!) | |||
|
Wednesday 10 October 2007 Facilitation: Dr Clive Ondari, PSM/PAR |
||||
| What is access? | ||||
| 09.00-10.30 | Panel presentation and discussion | |||
| Access framework, HIV/AIDS, TB and Malaria | ||||
| Dr Richard Laing | ||||
| Dr Vincent Habiyambere (HTM/HIV) | ||||
| Ms Silvia Schwarte (GMP/SCM) | ||||
| Mr Robert Matiru (GDF-TB) | ||||
| Ms Atieno Ojoo (UNICEF) |
WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies |
|||
| Ms Sophie Logez (GFATM) | ||||
| Mrs Helen Tata, TCM. |
Tool to Assess Procurement and Supply Management systems of Essential Medicines |
|||
|
Short presentations + Panel
discussion Background documentation:
Equitable access to essential medicines |
||||
| 10.30-10.45 | Coffee | |||
| 10.45-11.30 | Discussion | |||
| 11.30-12.30 |
Essential Medicines as a Human Right Dr Hans Hogerzeil, Director PSM
Background documentation: |
Access to essential medicines as part of the fulfilment of the Right to Health |
||
| 12.30-14.00 | Lunch
During lunch Dr Jorge Bermudez, Executive
Secretary of UNITAID will present a lecture on UNITAID. This will be held in
the Kofi A. Annan Conference Room, UNAIDS/WHO Building, and will be open to
all WHO and Geneva based staff: |
Together
to heal (PDF file) |
||
| Medicine prices and financing | ||||
| 14.00-15.15 | Medicine prices,
WHO/NGO Price Survey Methodology Dr Richard Laing, PSM/PAR, Ms Alexandra Cameron, PSM/PAR, Dr Gilles Forte, TCM/DAP
Background
documentation: |
|||
| 15.15-15.30 | Tea | |||
| 15.30-17.00 | Hot topic ideas: | |||
| Medicines promotion
- Dr Richard Laing, PAR |
Codes and regulations |
|||
|
Corruption & Good Governance for Medicines - Dr Guitelle Baghdadi-Sabeti,
PAR |
||||
|
Medicines Transparency Alliance (MeTA) - Dr Richard Laing and Alexandra
Cameron, PAR |
||||
|
Thursday 11
October 2007 Facilitation: Dr Gilles Forte and Mrs Helen Tata, TCM |
||||
| Technical collaboration with regions and countries | ||||
| 09.00-09.20 | WHO
TCM strategy for working with and in countries Harmonization and regional initiatives Mrs M. Matsoso, Director, TCM
Background
documentation: |
Working with Countries, Harmonisation and Regional Initiatives |
||
| 09.20-09.40 |
Strategy for working with countries Regional and Subregional perspective and experiences Dr K. Weerasuriya, RA/SEARO |
Strategies for Working with Countries – Regional and Sub-Regional Perspective and Experiences |
||
| 09.40-10.45 |
Medicines Procurement and Supply
Management Issues in the African Region Mrs Helen Tata, Mrs Magali Babaley (TCM), Mr Joël Adagadzu, Director, Food and Drugs, FMOH, Nigeria |
Mapping and In-depth Assessment of Medicines Procurement and Supply Systems Medicines Procurement and Supply Management Issues in Nigeria |
||
| 10.45-11.00 | Coffee | |||
| 11.00-11.40 | Discussion on regional and country activities. | |||
| 11.40-12.30 |
International Regulatory Cooperation for Herbal Medicines (IRCH) Dr Ziaorui Zhang, TCM/TRM |
Global review of the challenges in use of traditional medicine and WHO
perspective |
||
| 12.30-14.00 |
Lunch |
|||
| Global issues | ||||
| 14.00-15.30 |
Intellectual
property rights, trade agreements and access to medicines: WHO's mandate and
strategy in the implementation of the TRIPS Agreement and the Doha
Declaration Dr German Velasquez, TCM
Background
documentation: |
|||
| 15.30-16.00 | Tea | |||
| 16.00-17.00
|
Medicines Regulation and
Counterfeit Issues
Background
documentation: |
Impact: a WHO initiative to combat counterfeit medical products |
||
|
Friday 12 October 2007 Facilitation: Dr Richard Laing, PSM/PAR |
||||
| Safety | ||||
| 09.00-10.00 |
Pharmacovigilance: New challenges for WHO WHO Collaborating Centre, Uppsala PSM/QSM Dr Ronald Meyboom, WHO Collaborating Centre, Uppsala, PSM/QSM
Background
documentation: |
Pharmacovigilance and the WHO Collaborating Centre for International Drug Monitoring in Uppsala |
||
| What is rational medicine use? | ||||
| 10.00-12.30 | Promoting rational
use of medicines Dr Richard Laing, PSM/PAR
Background
documentation: |
|||
| 10.45-11.00 | Coffee | |||
| 12.30 | Closure Dr Hans V. Hogerzeil and Dr Kris Weerasuriya |
|||
| 14.00 | Additional time for sessions, individual appointments with TCM and PSM staff | |||